What is H.C. Wainwright's price target for AVTX?

H.C. Wainwright's latest stated price target for Avalo Therapeutics Inc. (AVTX) is $25, from its action on Sep 17, 2025.

What is H.C. Wainwright's rating on AVTX?

H.C. Wainwright rates AVTX Neutral, a neutral rating, as of Oct 23, 2026.

When did H.C. Wainwright last change its view on AVTX?

On Oct 23, 2026, H.C. Wainwright downgrades to Neutral from Buy.

Analyst firms · H.C. Wainwright · AVTX

H.C. Wainwright AVTX price target and rating history

Avalo Therapeutics Inc. (AVTX) · Health Care

H.C. Wainwright rates Avalo Therapeutics Inc. (AVTX) Neutral with a $25 price target, as of its latest action on Oct 23, 2026. It has published 4 rating actions on AVTX since October 2024, including 0 upgrades and 1 downgrade. Across 6 firms with a AVTX price target in the last 12 months, the median target is $43.50.

Current rating: Neutral
Price target: $25
Median target, all firms: $43.50
Actions on AVTX: 4

H.C. Wainwright price target on AVTX

H.C. Wainwright price target on AVTX, each point a stated target, June 2025 to September 2025.

Every H.C. Wainwright rating on AVTX

Oct 23, 2026
DowngradeH.C. Wainwright downgrades to Neutral from Buy
Sep 17, 2025
ReiterateH.C. Wainwright raises its price target to $25 from $15, keeps Buy
Jun 2, 2025
ResumeH.C. Wainwright resumes coverage at Buy, price target $15
Oct 24, 2024
InitiateH.C. Wainwright starts coverage at Neutral

How other firms rate AVTX

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Neutral		Oct 23, 2026
Guggenheim	Neutral	$50	Oct 23, 2026
Leerink Partners	Outperform	$38	Jul 6, 2026
BofA Securities	Buy	$35	Jun 12, 2026
Wolfe Research	Outperform	$48	Apr 9, 2026
Citizens JMP	Mkt Outperform	$52	Apr 6, 2026
Mizuho	Outperform	$39	Dec 18, 2025

Questions about H.C. Wainwright and AVTX

What is H.C. Wainwright's price target for AVTX?: H.C. Wainwright's latest stated price target for Avalo Therapeutics Inc. (AVTX) is $25, from its action on Sep 17, 2025.
What is H.C. Wainwright's rating on AVTX?: H.C. Wainwright rates AVTX Neutral, a neutral rating, as of Oct 23, 2026.
When did H.C. Wainwright last change its view on AVTX?: On Oct 23, 2026, H.C. Wainwright downgrades to Neutral from Buy.
How does H.C. Wainwright's AVTX target compare with other analysts?: Across 6 firms with a AVTX price target in the last 12 months, the median target is $43.50.

All H.C. Wainwright ratings AVTX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.